Automated Breast Cancer Screening and Risk Stratification Workflow

This workflow automates the repetitive, high-volume tasks of lesion segmentation, breast density calculation, and risk scoring from screening mammograms and MRIs. By orchestrating specialized AI models, it eliminates manual contouring and measurement, reducing radiologist interpretation time per case by 30-50%. The operational upside comes from increased screening throughput, standardized BI-RADS reporting, and the proactive identification of high-risk patients for enhanced surveillance, directly impacting early detection rates and program economics.

Implementation integrates directly with PACS (e.g., Epic, Sectra) and screening registries via HL7/FHIR. The orchestrator, built on LangGraph, manages data flow, exception routing, and audit trails. Critical controls include confidence scoring gates to flag low-certainty results for human review, physician override logging for model improvement, and real-time monitoring of model drift against gold-standard annotations to maintain diagnostic safety and regulatory compliance in production.

The operational bottleneck is manual lesion contouring, density assessment, and risk score calculation, which limits radiologist throughput and introduces reporting variability. This custom workflow automates these repetitive tasks by orchestrating specialized AI agents against incoming DICOM studies from PACS. The savings come from a 30-50% reduction in per-case reading time, allowing a fixed radiologist cohort to handle higher screening volumes while improving consistency in BI-RADS and Tyrer-Cuzick scoring for downstream care coordination.

Implementation requires deploying the orchestrator (e.g., LangGraph) to manage state and parallel agent execution, integrated via HL7/FHIR with Epic or Cerner EHRs and screening registries. Critical controls include a confidence-scoring gate to route low-confidence segmentations for radiologist review, an immutable audit trail for all overrides, and continuous performance monitoring against ground-truth biopsies. Rollout is sequenced by modality, starting with screening mammography before incorporating breast MRI, with governance ensuring all outputs remain preliminarily until physician sign-off in the reporting system.

Phase 1 establishes the core segmentation and risk engine, integrating with PACS to ingest DICOM studies. We deploy a containerized inference service for lesion segmentation and density calculation, with all outputs routed to a human-in-the-loop review queue in the existing radiologist workstation. This initial phase validates model performance in a controlled sandbox, measures time savings per read, and builds clinician trust without disrupting the primary diagnostic pathway. The business case is proven through reduced manual contouring time.

Phase 2 introduces orchestration and automated reporting. Approved findings from the review queue trigger a report-drafting agent that generates BI-RADS impressions and patient-facing summaries, pushing structured data to the EHR via FHIR. This phase requires robust approval gates and an audit trail for every AI-suggested finding. The operational upside comes from standardizing report quality and freeing radiologist time for complex cases. Phase 3 scales the workflow, integrating with screening registries for proactive outreach and implementing continuous performance monitoring to detect model drift and trigger retraining, ensuring long-term diagnostic accuracy and program capacity.

Operationalizing an automated screening workflow demands a governance-first architecture. Implementation begins with a pilot cohort, integrating the AI orchestrator with PACS/RIS and the EHR in read-only mode. All segmentation outputs and risk stratifications are routed through a mandatory human-in-the-loop review interface before any findings are committed to the patient record. This controlled sandbox phase validates model performance, clinician usability, and system integration stability, mitigating patient safety risk while building clinical trust.

Post-pilot, a phased rollout uses the confidence-scoring layer to auto-escalate low-certainty cases while streamlining high-confidence reads. A dedicated monitoring dashboard tracks key metrics: segmentation accuracy against a gold-standard subset, radiologist override rates, and report turnaround time. Any model drift or performance degradation triggers an automated alert and can freeze the workflow, routing all studies to manual review. Change management is codified via version-controlled model registries and requires re-validation against a held-out clinical test set before any model update is deployed, ensuring continuous safety and auditability.